TADALAFIL

sanis health inc🇨🇦 Health Canada

Approval Id: 1b6e262840d5fd2d
Drug Approval Canada Name: TADALAFIL
Product Name: TADALAFIL
Status: Marketed
Status Date: 2021-07-13
Original Market Date: 2021-07-13
Din: 02457032
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:12.12
Atc Original: G04BE08 TADALAFIL
Atc Name: g 04 be 08
Aig Number: 0149485002
Company Name: sanis health inc
Company Address: 1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5

TADALAFIL

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1b6e262840d5fd2d

Type

Standard